glp 1 is it a peptide Peptide-oligourea hybrids analogue of GLP-1 with improved action in vivo The GLP-1 boom: Challenges, trends,

Activation of these receptors may modulate dopamine signaling, potentially reducing alcohol's rewarding properties, though the exact mechanisms in humans remain under investigation

BMJ 383 , 2906 (2023)

the improvement is only relative to the extremely high levels they experienced across the past year

The cardiovascular outcomes trials that enrolled tens of thousands of patients with type 2 diabetesincluding LEADER (liraglutide), SUSTAIN-6 (semaglutide), REWIND (dulaglutide), and EXSCEL (exenatide ER)found no significant increase in overall cancer incidence compared to placebo over follow-up periods ranging from approximately two to five years